Nasdaq
CLRB
Cellectar Biosciences, Inc.
- Health Care
- 1 day
- +0.0%
- 1 month
- −6.7%
- 1 year
- −47.3%
$2.52 · Mkt cap $20.1M
At the 6 Aug 2026 close
Nasdaq
Cellectar Biosciences, Inc.
$2.52 · Mkt cap $20.1M
At the 6 Aug 2026 close
Cellectar Biosciences, Inc. trades under the ticker CLRB on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $20.1M. The last closing price was $2.52, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −47.3%, and −6.7% over the past month. Returns are price returns and exclude dividends.
This page exists because CLRB is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.